916812-31-2 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
6-Bromo-N-methyl-4-quinolinamine is used as a building block for the synthesis of potential drugs, contributing to the development of new therapeutic agents. Its unique chemical structure and properties make it valuable for studying its biological activity and exploring its potential therapeutic applications.
Used in Analytical Purposes:
6-Bromo-N-methyl-4-quinolinamine serves as a reference standard in analytical processes, ensuring the accuracy and reliability of experimental results. Its well-defined chemical properties allow for precise measurements and comparisons in various analytical techniques.
Used in Material Science:
In the field of material science, 6-Bromo-N-methyl-4-quinolinamine may be utilized for the development of novel materials with specific properties. Its chemical structure can be manipulated to create materials with tailored characteristics, such as improved stability, reactivity, or selectivity.
Used in Organic Synthesis:
6-Bromo-N-methyl-4-quinolinamine is employed as a key intermediate in organic synthesis, enabling the production of a wide range of organic compounds. Its reactivity and functional groups make it a useful building block for the synthesis of complex organic molecules with diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 916812-31-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,6,8,1 and 2 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 916812-31:
(8*9)+(7*1)+(6*6)+(5*8)+(4*1)+(3*2)+(2*3)+(1*1)=172
172 % 10 = 2
So 916812-31-2 is a valid CAS Registry Number.
916812-31-2Relevant academic research and scientific papers
HETEROCYCLIC CARBOXYLIC ACID AMIDES AS PDK1 INIHIBITORS
-
Page/Page column 93; 95, (2011/11/06)
The present invention encompasses compounds of general formula (1) wherein the groups R1 to R4, Qa, Qb, QH, L and n are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.
NOVEL CHEMICAL COMPOUNDS
-
Page/Page column 46, (2010/11/25)
This invention relates to newly identified compounds for inhibiting hYAK3 proteins and methods for treating diseases associated with hYAK3 activity.
